Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaaki Inaba

Showing results (81-90 of 430) with videos related to

Pageof 43
Sort By:
Journal of Bone and Mineral Metabolism|July 29, 2021
Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational studyMotohiko Sato, Masaaki Inaba, Shinsuke Yamada, et al.
Kidney International Reports|July 11, 2022
In Reply to "Letter Regarding 'Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan-A Phase 2 Randomized Trial'"Masaaki Inaba, Yotaro Une, Kazuaki Ikejiri, et al.
Internal Medicine (Tokyo, Japan)|May 18, 2005
Hypercalcemia in a patient with primary hyperparathyroidism and acromegaly: distinct roles of growth hormone and parathyroid hormone in the development of hypercalcemiaMisako Ueda, Masaaki Inaba, Hideki Tahara, et al.
Clinical Calcium|November 11, 2005
[Clinical effect of introduction of sevelamer hydrochloride in patients with hyperphosphatemia undergoing maintenance dialysis]Hideki Tahara, Yoshihiro Tsujimoto, Tetsuo Shouji, et al.
Scientific Reports|April 3, 2020
Geriatric Nutritional Risk Index (GNRI) and Creatinine Index Equally Predict the Risk of Mortality in Hemodialysis Patients: J-DOPPSShunsuke Yamada, Shungo Yamamoto, Shingo Fukuma, et al.
Advances in Experimental Medicine and Biology|March 15, 2022
Fibroblast Growth Factor 23 as Regulator of Vitamin D MetabolismShinya Nakatani, Ayumi Nakatani, Katsuhito Mori, et al.
Clinical and Experimental Nephrology|January 14, 2017
An introduction to CKD-MBD research: restart for the futureMasafumi Fukagawa, Masaaki Inaba, Keitaro Yokoyama, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 11, 2007
Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' diseaseToshiki Nagasaki, Masaaki Inaba, Yasuro Kumeda, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|January 4, 2015
Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormoneMasaaki Inaba, Senji Okuno, Harumi Nagayama, et al.
Metabolism: Clinical and Experimental|July 19, 2003
Association of muscle glycogen synthase polymorphism with insulin resistance in type 2 diabetic patientsKoka Motoyama, Masanori Emoto, Hideki Tahara, et al.
Pageof 43

Showing results (81-90 of 430) with videos related to

Sort By:
Pageof 43
Journal of Bone and Mineral Metabolism|July 29, 2021
Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational studyMotohiko Sato, Masaaki Inaba, Shinsuke Yamada, et al.
Kidney International Reports|July 11, 2022
In Reply to "Letter Regarding 'Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan-A Phase 2 Randomized Trial'"Masaaki Inaba, Yotaro Une, Kazuaki Ikejiri, et al.
Internal Medicine (Tokyo, Japan)|May 18, 2005
Hypercalcemia in a patient with primary hyperparathyroidism and acromegaly: distinct roles of growth hormone and parathyroid hormone in the development of hypercalcemiaMisako Ueda, Masaaki Inaba, Hideki Tahara, et al.
Clinical Calcium|November 11, 2005
[Clinical effect of introduction of sevelamer hydrochloride in patients with hyperphosphatemia undergoing maintenance dialysis]Hideki Tahara, Yoshihiro Tsujimoto, Tetsuo Shouji, et al.
Scientific Reports|April 3, 2020
Geriatric Nutritional Risk Index (GNRI) and Creatinine Index Equally Predict the Risk of Mortality in Hemodialysis Patients: J-DOPPSShunsuke Yamada, Shungo Yamamoto, Shingo Fukuma, et al.
Advances in Experimental Medicine and Biology|March 15, 2022
Fibroblast Growth Factor 23 as Regulator of Vitamin D MetabolismShinya Nakatani, Ayumi Nakatani, Katsuhito Mori, et al.
Clinical and Experimental Nephrology|January 14, 2017
An introduction to CKD-MBD research: restart for the futureMasafumi Fukagawa, Masaaki Inaba, Keitaro Yokoyama, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 11, 2007
Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' diseaseToshiki Nagasaki, Masaaki Inaba, Yasuro Kumeda, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|January 4, 2015
Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormoneMasaaki Inaba, Senji Okuno, Harumi Nagayama, et al.
Metabolism: Clinical and Experimental|July 19, 2003
Association of muscle glycogen synthase polymorphism with insulin resistance in type 2 diabetic patientsKoka Motoyama, Masanori Emoto, Hideki Tahara, et al.
Pageof 43